Brokerages Set Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) PT at $12.33

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) has earned a consensus rating of “Moderate Buy” from the six brokerages that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price target […]

Related Keywords

United States ,Canada ,Stephenp Robertson ,Georgem Milne Jr , ,Aurinia Pharmaceuticals ,Analyst Recommendations For Aurinia Pharmaceuticals ,International Biotechnology Trust ,Institutional Investors Weigh In On Aurinia Pharmaceuticals ,Royal Bank ,Nasdaq ,Dupont Capital Management Corp ,Aurinia Pharmaceuticals Inc ,News Ratings For Aurinia Pharmaceuticals Daily ,Tang Capital Management ,Aurinia Pharmaceuticals Trading Down ,Legacy Advisors ,Get Rating ,Director George ,Capital Management ,Biotechnology Trust ,Capital Management Corp ,Quantbot Technologies ,Pharmaceuticals Trading Down ,Pharmaceuticals Inc ,Aurinia Pharmaceuticals Daily ,Nasdaq Auph ,Auph ,Medical ,Ratings ,Consensus ,